Date: 26-Aug-2019

Central drug regulator preparing list of dual-use APIs imported from unregistered firms

The central drug regulator is preparing a list of active pharmaceutical ingredients (APIs), the chemicals used for making medicines that have dual-use and are being frequently imported from unregistered firms, to stop their misuse and improve quality, officials said.